Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 222

1.

Elevated GlycA in Severe Obesity is Normalized by Bariatric Surgery.

Manmadhan A, Lin BX, Zhong J, Parikh M, Berger JS, Fisher EA, Heffron SP.

Diabetes Obes Metab. 2018 Jul 25. doi: 10.1111/dom.13481. [Epub ahead of print]

PMID:
30047224
2.

Deciphering the Role of Lipid Droplets in Cardiovascular Disease: A Report From the 2017 National Heart, Lung, and Blood Institute Workshop.

Goldberg IJ, Reue K, Abumrad NA, Bickel PE, Cohen S, Fisher EA, Galis ZS, Granneman JG, Lewandowski ED, Murphy R, Olive M, Schaffer JE, Schwartz-Longacre L, Shulman GI, Walther TC, Chen J.

Circulation. 2018 Jul 17;138(3):305-315. doi: 10.1161/CIRCULATIONAHA.118.033704. Review.

PMID:
30012703
3.

Human Aldose Reductase Expression Prevents Atherosclerosis Regression in Diabetic Mice.

Yuan C, Hu J, Parathath S, Grauer L, Cassella CB, Bagdasarov S, Goldberg IJ, Ramasamy R, Fisher EA.

Diabetes. 2018 Jun 11. pii: db180156. doi: 10.2337/db18-0156. [Epub ahead of print]

PMID:
29891593
4.

Insights From Pre-Clinical and Clinical Studies on the Role of Innate Inflammation in Atherosclerosis Regression.

Rahman K, Fisher EA.

Front Cardiovasc Med. 2018 May 11;5:32. doi: 10.3389/fcvm.2018.00032. eCollection 2018.

5.

Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial.

Gianos E, Schoenthaler A, Guo Y, Zhong J, Weintraub H, Schwartzbard A, Underberg J, Schloss M, Newman JD, Heffron S, Fisher EA, Berger JS.

Am Heart J. 2018 May;199:37-43. doi: 10.1016/j.ahj.2017.12.019. Epub 2018 Jan 9.

PMID:
29754664
6.

Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?

Doonan LM, Fisher EA, Brodsky JL.

Biochim Biophys Acta. 2018 Jul;1863(7):762-771. doi: 10.1016/j.bbalip.2018.03.010. Epub 2018 Apr 6. Review.

PMID:
29627384
7.

Statin dose reduction with complementary diet therapy: A pilot study of personalized medicine.

Scolaro B, Nogueira MS, Paiva A, Bertolami A, Barroso LP, Vaisar T, Heffron SP, Fisher EA, Castro IA.

Mol Metab. 2018 May;11:137-144. doi: 10.1016/j.molmet.2018.02.005. Epub 2018 Feb 20.

8.

Changes in lipoprotein(a) following bariatric surgery.

Lin BX, Weiss MC, Parikh M, Berger JS, Fisher EA, Heffron SP.

Am Heart J. 2018 Mar;197:175-176. doi: 10.1016/j.ahj.2017.10.020. Epub 2017 Nov 4. No abstract available.

PMID:
29447779
9.

Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis.

Seijkens TTP, van Tiel CM, Kusters PJH, Atzler D, Soehnlein O, Zarzycka B, Aarts SABM, Lameijer M, Gijbels MJ, Beckers L, den Toom M, Slütter B, Kuiper J, Duchene J, Aslani M, Megens RTA, van 't Veer C, Kooij G, Schrijver R, Hoeksema MA, Boon L, Fay F, Tang J, Baxter S, Jongejan A, Moerland PD, Vriend G, Bleijlevens B, Fisher EA, Duivenvoorden R, Gerdes N, de Winther MPJ, Nicolaes GA, Mulder WJM, Weber C, Lutgens E.

J Am Coll Cardiol. 2018 Feb 6;71(5):527-542. doi: 10.1016/j.jacc.2017.11.055.

10.

Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor.

Basu D, Hu Y, Huggins LA, Mullick AE, Graham MJ, Wietecha T, Barnhart S, Mogul A, Pfeiffer K, Zirlik A, Fisher EA, Bornfeldt KE, Willecke F, Goldberg IJ.

Circ Res. 2018 Feb 16;122(4):560-567. doi: 10.1161/CIRCRESAHA.117.311361. Epub 2018 Jan 10. Review.

PMID:
29321129
11.

Autophagy Is Required for Sortilin-Mediated Degradation of Apolipoprotein B100.

Amengual J, Guo L, Strong A, Madrigal-Matute J, Wang H, Kaushik S, Brodsky JL, Rader DJ, Cuervo AM, Fisher EA.

Circ Res. 2018 Feb 16;122(4):568-582. doi: 10.1161/CIRCRESAHA.117.311240. Epub 2018 Jan 4.

PMID:
29301854
12.

High-Density Lipoprotein Nanobiologics for Precision Medicine.

Mulder WJM, van Leent MMT, Lameijer M, Fisher EA, Fayad ZA, Pérez-Medina C.

Acc Chem Res. 2018 Jan 16;51(1):127-137. doi: 10.1021/acs.accounts.7b00339. Epub 2017 Dec 27.

PMID:
29281244
13.

Changes in High-Density Lipoprotein Cholesterol Efflux Capacity After Bariatric Surgery Are Procedure Dependent.

Heffron SP, Lin BX, Parikh M, Scolaro B, Adelman SJ, Collins HL, Berger JS, Fisher EA.

Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):245-254. doi: 10.1161/ATVBAHA.117.310102. Epub 2017 Nov 21.

PMID:
29162605
14.

Analysis of Hepatitis C Virus Particle Heterogeneity in Immunodeficient Human Liver Chimeric fah-/- Mice.

Andreo U, de Jong YP, Scull MA, Xiao JW, Vercauteren K, Quirk C, Mommersteeg MC, Bergaya S, Menon A, Fisher EA, Rice CM.

Cell Mol Gastroenterol Hepatol. 2017 Jul 19;4(3):405-417. doi: 10.1016/j.jcmgh.2017.07.002. eCollection 2017 Nov.

15.

Diabetes-mediated myelopoiesis and the relationship to cardiovascular risk.

Barrett TJ, Murphy AJ, Goldberg IJ, Fisher EA.

Ann N Y Acad Sci. 2017 Aug;1402(1):31-42. doi: 10.1111/nyas.13462. Review.

16.

Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr-/- Mice.

Yu M, Amengual J, Menon A, Kamaly N, Zhou F, Xu X, Saw PE, Lee SJ, Si K, Ortega CA, Choi WI, Lee IH, Bdour Y, Shi J, Mahmoudi M, Jon S, Fisher EA, Farokhzad OC.

Adv Healthc Mater. 2017 Oct;6(20). doi: 10.1002/adhm.201700313. Epub 2017 Jul 21.

PMID:
28730752
17.

Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association.

Daugherty A, Tall AR, Daemen MJAP, Falk E, Fisher EA, García-Cardeña G, Lusis AJ, Owens AP 3rd, Rosenfeld ME, Virmani R; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Basic Cardiovascular Sciences.

Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):e131-e157. doi: 10.1161/ATV.0000000000000062. Epub 2017 Jul 20. Review.

PMID:
28729366
18.

Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association.

Daugherty A, Tall AR, Daemen MJAP, Falk E, Fisher EA, García-Cardeña G, Lusis AJ, Owens AP 3rd, Rosenfeld ME, Virmani R; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Basic Cardiovascular Sciences.

Circ Res. 2017 Sep 1;121(6):e53-e79. doi: 10.1161/RES.0000000000000169. Epub 2017 Jul 20. Review.

PMID:
28729353
19.

Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression.

Rahman K, Vengrenyuk Y, Ramsey SA, Vila NR, Girgis NM, Liu J, Gusarova V, Gromada J, Weinstock A, Moore KJ, Loke P, Fisher EA.

J Clin Invest. 2017 Aug 1;127(8):2904-2915. doi: 10.1172/JCI75005. Epub 2017 Jun 26.

20.

Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes.

Kraakman MJ, Lee MK, Al-Sharea A, Dragoljevic D, Barrett TJ, Montenont E, Basu D, Heywood S, Kammoun HL, Flynn M, Whillas A, Hanssen NM, Febbraio MA, Westein E, Fisher EA, Chin-Dusting J, Cooper ME, Berger JS, Goldberg IJ, Nagareddy PR, Murphy AJ.

J Clin Invest. 2017 Jun 1;127(6):2133-2147. doi: 10.1172/JCI92450. Epub 2017 May 15.

Supplemental Content

Loading ...
Support Center